{
  "url": "https://openlegislation.uk/medicines-marketing-authorisations-and-miscellaneous-amendments-regulations-2004/regulation-9",
  "json_url": "https://openlegislation.uk/medicines-marketing-authorisations-and-miscellaneous-amendments-regulations-2004/regulation-9.json",
  "legislation": "uksi/2004/3224",
  "legislation_title": "The Medicines (Marketing Authorisations and Miscellaneous Amendments) Regulations 2004",
  "legislation_url": "https://openlegislation.uk/medicines-marketing-authorisations-and-miscellaneous-amendments-regulations-2004",
  "path": "regulation/9",
  "kind": "regulation",
  "number": "9",
  "heading": "Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004",
  "text": "In the Medicines for Human Use (Clinical Trials) Regulations 2004, in regulation 2 (interpretation), in paragraph (1), for the definition of “the European Medicines Agency” substitute the following definition—\n““the European Medicines Agency” means the European Medicines Agency established by Regulation (EC) No. 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency;”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2004/1031."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2004/3224/regulation/9",
    "retrieved_at": "2026-10-29T05:13:58.988390+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}